Godavari Biorefineries Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Near 52-week low — potential value zone (₹227)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| HINDUNILVR Hindustan Unilever Limited | ₹1,973 | ₹4.6L Cr | 42 | 9.53 | 31 | 28.4 | 0.04 |
| ITC ITC Limited | ₹264 | ₹3.3L Cr | 16.8 | 4.56 | 29.3 | 38.9 | 0.01 |
| NESTLEIND Nestle India Limited | ₹1,411 | ₹2.7L Cr | 73.4 | 52.83 | 74.2 | 85.3 | 0.09 |
| VBL Varun Beverages Limited | ₹408 | ₹1.4L Cr | 40.7 | 7.04 | 16.2 | 19.7 | 0.13 |
| BRITANNIA Britannia Industries Limited | ₹5,102 | ₹1.2L Cr | 47.2 | 24.06 | 53.5 | 56 | 0.59 |
| UNITDSPR United Spirits Limited | ₹1,472 | ₹1.1L Cr | 57.8 | 11.97 | 21.4 | 26.4 | 0.05 |
| MARICO Marico Limited | ₹815 | ₹1.1L Cr | 56.1 | 25.16 | 42.8 | 47 | 0.14 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
GODAVARIB · as of Jun 2026
| Category | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 63.31% | 63.31% | 63.31% | 63.31% | 63.31% | 63.31% |
| FII | 0.96% | 0.63% | 0.60% | 0.86% | 0.98% | 0.22% |
| DII | 14.17% | 13.98% | 11.98% | 11.16% | 10.39% | 10.02% |
| Public | 21.56% | 22.09% | 24.11% | 24.67% | 25.31% | 26.44% |
Corporate Events
To consider and approve the financial results for the quarter and year ended on March 31, 2026
Latest News
All newsGodavari Biorefineries secures European patent for pharmaceutical composition
*Godavari Biorefineries secures European patent for pharmaceutical composition.* The European Patent Office has granted a patent for its 'Pharmaceutical Composition and a Process to Prepare the Same'. This strengthens the company's intellectual property portfolio and may enhance product differentiation in international markets. The development reflects ongoing R&D efforts in specialty pharma formulations. 📊 *STOCKS:* $GODAVARI | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Patent
Godavari Biorefineries wins cancer treatment patent in Japan
*Godavari Biorefineries wins cancer treatment patent in Japan*. The Japanese Patent Office granted a patent for '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER'. This strengthens GBRL’s global IP portfolio and validates its R&D focus in oncology. Clinical and commercial success could drive future revenue streams. 📊 *STOCKS:* GBRL | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Patent
Godavari Biorefineries publishes notice in newspaper
*Godavari Biorefineries publishes notice in newspaper* as part of regulatory compliance. The filing is a routine copy of a newspaper publication, likely related to annual general meeting or statutory disclosure. No financial or operational details were disclosed. Such notices are standard and do not impact near-term business performance. 📊 *STOCKS:* $GODAVARI | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Corporate
Godavari Biorefineries notifies re-lodgement window for physical shares
*Godavari Biorefineries notifies re-lodgement window for physical shares.* The company has announced a special window for re-submitting transfer deeds for physical shares. This facilitates investors who faced issues during earlier submission. No financial impact is expected from this procedural update. 📊 *STOCKS:* $GODAVARI | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #PhysicalShares
Godawari Power to discuss performance in investor meet
*Godawari Power to discuss performance in investor meet* — The company is hosting an analyst and institutional investor meet to review recent operational and financial performance. Details from the con-call transcript may offer insights into future outlook and strategy. No major announcements or financial revisions were disclosed. 📊 *STOCKS:* $GODAVARIPF | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InvestorMeet
Godawari Power to host Q1FY27 results call on Aug 10
*Godawari Power to host Q1FY27 results call on Aug 10.* The company will conduct an analyst and institutional investor meet following its Q1 earnings release. Event scheduled for August 10, 2026. Investors await updates on performance and guidance. 📊 *STOCKS:* $GODAVARIPFR | 🏢 *SECTOR:* Energy | #LOWIMPACT #Earnings
Godavari Biorefineries publishes re-lodgement notice for physical shares
*Godavari Biorefineries publishes re-lodgement notice for physical shares* — The company has issued a newspaper publication for the special window to re-lodge transfer requests of physical shares. This is a procedural step for shareholders holding physical certificates. No financial impact is expected. 📊 *STOCKS:* GODAVARISUG | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #PhysicalShares
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹460 Cr 6.7% | ₹431 Cr 19.1% | ₹533 Cr 8.1% | ₹580 Cr 29.8% | ₹447 Cr 39.3% | ₹321 Cr 38.6% | ₹523 Cr 15.0% | ₹615.19 Cr |
| Op. Profit | ₹43 Cr 637.5% | ₹-8 Cr 233.3% | ₹6 Cr 94.6% | ₹112 Cr 211.1% | ₹36 Cr 209.1% | ₹-33 Cr 175.0% | ₹-12 Cr 110.5% | ₹113.83 Cr |
| OPM | 9.0% 550.0% | -2.0% 300.0% | 1.0% 94.7% | 19.0% 137.5% | 8.0% 180.0% | -10.0% 400.0% | -2.0% 110.8% | 18.5% |
| Net Profit | ₹8 Cr 119.0% | ₹-42 Cr 162.5% | ₹-16 Cr 122.2% | ₹72 Cr 1100.0% | ₹6 Cr 108.0% | ₹-75 Cr 188.5% | ₹-26 Cr 139.9% | ₹65.17 Cr |
| EPS (₹) | 1.61 119.8% | -8.13 159.7% | -3.13 122.3% | 14.06 1144.2% | 1.13 106.3% | -17.88 187.0% | -6.23 140.1% | 15.54 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹2.0K Cr 6.3% | ₹1.9K Cr 10.8% | ₹1.7K Cr 16.3% | ₹2.0K Cr 18.4% | ₹1.7K Cr 10.7% | ₹1.5K Cr 5.4% | ₹1.5K Cr |
| Expenses | ₹1.9K Cr 5.4% | ₹1.8K Cr 13.7% | ₹1.6K Cr 16.8% | ₹1.9K Cr 19.1% | ₹1.6K Cr 13.5% | ₹1.4K Cr 1.8% | ₹1.4K Cr |
| Op. Profit | ₹127 Cr 22.1% | ₹104 Cr 22.4% | ₹134 Cr 8.8% | ₹147 Cr 9.7% | ₹134 Cr 15.2% | ₹158 Cr 53.4% | ₹103 Cr |
| OPM | 6.0% 0.0% | 6.0% 25.0% | 8.0% 14.3% | 7.0% 12.5% | 8.0% 20.0% | 10.0% 42.9% | 7.0% |
| Other Income | ₹-19 Cr 218.8% | ₹16 Cr 14.3% | ₹14 Cr 100.0% | ₹7 Cr 16.7% | ₹6 Cr 25.0% | ₹8 Cr 42.9% | ₹14 Cr |
| Interest | ₹49 Cr 31.9% | ₹72 Cr 5.3% | ₹76 Cr 4.1% | ₹73 Cr 21.7% | ₹60 Cr 16.7% | ₹72 Cr 4.3% | ₹69 Cr |
| Depreciation | ₹54 Cr 8.0% | ₹50 Cr 16.7% | ₹60 Cr 20.0% | ₹50 Cr 4.2% | ₹48 Cr 2.1% | ₹47 Cr 4.4% | ₹45 Cr |
| PBT | ₹5 Cr 350.0% | ₹-2 Cr 116.7% | ₹12 Cr 62.5% | ₹32 Cr 0.0% | ₹32 Cr 30.4% | ₹46 Cr 1433.3% | ₹3 Cr |
| Tax % | 23.0% 98.4% | 1421.0% 142000.0% | 1.0% 97.4% | 38.0% 5.0% | 40.0% 2.4% | 41.0% 270.8% | -24.0% |
| Net Profit | ₹4 Cr 117.4% | ₹-23 Cr 291.7% | ₹12 Cr 40.0% | ₹20 Cr 5.3% | ₹19 Cr 29.6% | ₹27 Cr 575.0% | ₹4 Cr |
| EPS (₹) | 0.69 115.1% | -4.57 256.0% | 2.93 37.4% | 4.68 2.9% | 4.55 29.7% | 6.47 567.0% | 0.97 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||
| Equity Capital | ₹51 Cr 0.0% | ₹51 Cr 0.0% | ₹51 Cr 21.4% | ₹42 Cr 0.0% | ₹42 Cr 0.0% | ₹42 Cr 0.0% | ₹42 Cr 0.0% | ₹42 Cr |
| Reserves | ₹737 Cr 9.3% | ₹674 Cr 7.8% | ₹731 Cr 59.3% | ₹459 Cr 2.5% | ₹448 Cr 3.9% | ₹431 Cr 4.6% | ₹412 Cr 7.0% | ₹385 Cr |
| Borrowings | ₹531 Cr 7.7% | ₹493 Cr 0.6% | ₹490 Cr 25.2% | ₹655 Cr 11.0% | ₹736 Cr 15.7% | ₹636 Cr 11.8% | ₹569 Cr 3.4% | ₹589 Cr |
| Other Liabilities | ₹733 Cr 198.0% | ₹246 Cr 64.0% | ₹683 Cr 18.3% | ₹836 Cr 61.4% | ₹518 Cr 17.1% | ₹625 Cr 49.2% | ₹419 Cr 0.2% | ₹418 Cr |
| Total Liabilities | ₹2.1K Cr 40.3% | ₹1.5K Cr 25.2% | ₹2.0K Cr 1.9% | ₹2.0K Cr 14.2% | ₹1.7K Cr 0.6% | ₹1.7K Cr 20.2% | ₹1.4K Cr 0.6% | ₹1.4K Cr |
Assets | ||||||||
| Fixed Assets | ₹885 Cr 2.9% | ₹860 Cr 0.2% | ₹862 Cr 1.4% | ₹850 Cr 1.8% | ₹866 Cr 29.8% | ₹667 Cr 5.8% | ₹708 Cr 3.7% | ₹735 Cr |
| CWIP | ₹129 Cr 59.3% | ₹81 Cr 118.9% | ₹37 Cr 27.6% | ₹29 Cr 70.6% | ₹17 Cr 66.0% | ₹50 Cr 455.6% | ₹9 Cr 47.1% | ₹17 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹1.0K Cr 98.9% | ₹522 Cr 50.5% | ₹1.1K Cr 5.2% | ₹1.1K Cr 29.4% | ₹860 Cr 15.4% | ₹1.0K Cr 40.1% | ₹725 Cr 6.1% | ₹683 Cr |
| Total Assets | ₹2.1K Cr 40.3% | ₹1.5K Cr 25.2% | ₹2.0K Cr 1.9% | ₹2.0K Cr 14.2% | ₹1.7K Cr 0.6% | ₹1.7K Cr 20.2% | ₹1.4K Cr 0.6% | ₹1.4K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹171 Cr 2750.0% | ₹6 Cr 96.8% | ₹185 Cr 6.1% | ₹197 Cr 337.8% | ₹45 Cr 65.4% | ₹130 Cr 48.0% | ₹250 Cr |
| Investing CF | ₹-163 Cr 136.2% | ₹-69 Cr 56.8% | ₹-44 Cr 79.4% | ₹-214 Cr 345.8% | ₹-48 Cr 585.7% | ₹-7 Cr 69.6% | ₹-23 Cr |
| Financing CF | ₹-6 Cr 109.4% | ₹64 Cr 142.4% | ₹-151 Cr 639.3% | ₹28 Cr 366.7% | ₹6 Cr 105.0% | ₹-121 Cr 46.5% | ₹-226 Cr |
| Net Cash Flow | ₹3 Cr 200.0% | ₹1 Cr 110.0% | ₹-10 Cr 190.9% | ₹11 Cr 266.7% | ₹3 Cr 50.0% | ₹2 Cr 100.0% | ₹1 Cr |
| Free Cash Flow | ₹6 Cr 109.2% | ₹-65 Cr 150.0% | ₹130 Cr 750.0% | ₹-20 Cr 300.0% | ₹-5 Cr 104.2% | ₹119 Cr 46.6% | ₹223 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 21d 22.2% | 27d 34.1% | 41d 10.8% | 37d 0.0% | 37d 7.5% | 40d 29.0% | 31d |
| Inventory Days | 198d 1.5% | 195d 22.0% | 250d 82.5% | 137d 31.5% | 200d 37.0% | 146d 12.3% | 130d |
| Days Payable | 146d 4.3% | 140d 28.2% | 195d 85.7% | 105d 40.3% | 176d 33.3% | 132d 7.3% | 123d |
| Cash Conv. Cycle | 74d 9.8% | 82d 13.7% | 95d 39.7% | 68d 11.5% | 61d 10.9% | 55d 41.0% | 39d |
| Working Capital Days | 16d 23.8% | 21d 250.0% | -14d 800.0% | 2d 33.3% | 3d 200.0% | 1d 101.5% | -68d |
| ROCE | 7.0% 16.7% | 6.0% 14.3% | 7.0% 22.2% | 9.0% 0.0% | 9.0% 25.0% | 12.0% | — |
Source: Screener.in · Lower days = better efficiency
About Godavari Biorefineries Limited
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
Fast Moving Consumer GoodsDiversified FMCG